ABSTRACT Tyrosine aminotransferase (L-tyrosine:2-oxoglutarate aminotransferase, EC 2.6.1.5) enzyme and mRNA activity were not detectable in day 20 fetal rat liver. Precocious induction of catalytic activity by in utero injection of dibutyryl cAMP was a direct consequence ofthe de novo appearance oftranslatable tyrosine aminotransferase mRNA. In contrast, in utero injection ofhydrocortisone acetate failed to elicit fetal liver enzyme activity. This failure was due to the inability of the steroid hormone to induce the appearance of tyrosine aminotransferase mRNA activity. In fetal rat liver explants, either compound was capable of stimulating the synthesis of adult levels of enzyme and mRNA. However, catalytic and mRNA activity comparable with that seen in vivo 24 hr after birth required the concerted action of both inducers.
One of the central problems in the study of development is the determination of the factors responsible for differential gene expression and the appearance of tissue-specific proteins. The enzymatic differentiation of developing rat liver has proved to be a useful model for these studies. During development, most rat liver enzymes accumulate rapidly and in discrete groups or clusters: the late fetal cluster (16) (17) (18) (19) (20) (21) (22) days ofgestation), the neonatal cluster, and the late suckling cluster (1) .
Tyrosine aminotransferase (L-tyrosine:2-oxoglutarate aminotransferase, EC 2.6.1.5) is one of the enzymes appearing in the neonatal cluster (1) . Enzyme activity, virtually absent in fetal rat liver, starts to increase 2 hr after birth, reaching a maximum of at least twice the adult level by 12 hr. The catalytic activity then decreases to adult level by 2 days after birth (2, 3) . Premature appearance of tyrosine aminotransferase can be elicited in fetal rats by in utero injection of glucagon (4, 5) or dibutyryl cAMP (6) ; glucocorticoid injection does not precociously induce catalytic activity (4, 6) . However, all three compounds induce enzyme activity in vitro (7) (8) (9) .
As part of our studies on the regulation of tyrosine aminotransferase gene expression, we are investigating the process responsible for the appearance of tyrosine aminotransferase in newborn rats. We present evidence that the appearance of enzyme activity after precocious induction in utero is a direct consequence of the de novo accumulation of mRNA coding for tyrosine aminotransferase. In addition, we have used fetal rat liver explants to correlate tyrosine aminotransferase mRNA and enzyme activity during induction by dibutyryl cAMP and hydrocortisone acetate.
MATERIALS AND METHODS Chemicals. Cortef acetate (hydrocortisone acetate, 50 mg/ ml) was provided by Upjohn. BGJb medium, Fitton-Jackson modification, and penicillin/streptomycin (penicillin, 10,000 units/ml; streptomycin, 10,000 Ag/ml) were from GIBCO. Translation grade [3S]methionine (specific activity, 1350-1450 Ci/mmol; 1 Ci = 3.7 X 101°becquerels) was from Amersham. Cordycepin, protein A-Sepharose, and other biochemicals were from Sigma.
Animals. Sprague-Dawley (CD) rats from Charles River Breeding Laboratories were mated overnight. The morning that sperm were found in a vaginal smear was designated day 1 of pregnancy or gestation.
In Vivo Procedures. Timed pregnant females in day 20 of gestation were anesthetized with ether and the uteri were exposed. Each fetus was injected intraperitoneally through the uterine wall (6) with 0.05 ml of20 mM dibutyryl cAMP, 7.9 mM hydrocortisone acetate, or 0.9% NaCl. The dams were sacrificed by cervical dislocation 6 hr later. The fetuses were removed from the uterus, weighed, and decapitated. Fetal livers were removed, rinsed in cold water, blotted dry, and frozen in liquid nitrogen. Samples were stored at -70'C.
Organ Culture. The organ explant system used was that described by Simkins et al. (10) with modifications. After excision, fetal livers were rinsed in cold culture medium and manually cut into 1.5-mm cubes. Each cube was cultured on a 7-mmdiameter Millipore filter (0.45 tum) in a 16-mm well (Costar, Cambridge, MA) containing 0.2 ml of medium. The culture medium was BGJb medium, Fitton-Jackson modification/20 mM Hepes, pH 7.6, supplemented with penicillin at 100 units/ ml and streptomycin at 100 pug/ml. Before use, the medium was equilibrated at 37°C with water-saturated 95% air/5% CO2. Fresh medium was provided every 24 hr.
Assays. Tyrosine aminotransferase activity was assayed by a procedure adapted from Granner and Tomkins (11) . One unit of enzyme catalyzes the formation of 1 nmol of p-hydroxyphenylpyruvate per min at 37°C. Protein content was determined by the Lowry method. Actual tyrosine aminotransferase activity was distinguished from tyrosine deamination by aspartate aminotransferase (EC 2.6.1.1) (12) by incubating part of the liver homogenate before assay with goat anti-rat tyrosine aminotransferase IgG to inhibit tyrosine aminotransferase catalytic activity. The difference in activity between the antibody-treated and the untreated homogenates is a measure of true tyrosine aminotransferase activity.
RNA for translation was isolated by a modification of the guanidine hydrochloride extraction procedures of Chirgwin et al. (13) and Ullrich et al. (14) . Two grams of liver from injected animals or 22 explants was homogenized in extraction buffer (6 M guanidine hydrochloride/25 mM Tris HCl/5 mM EDTA, pH 7.5). The homogenate was adjusted to 33.3% ethanol, and the nucleic acids were precipitated overnight at -20°C. The sample was centrifuged at 20,000 X g for 15 min and the pellet was suspended in fresh extraction buffer. This was layered over a CsCl cushion (5.7 M CsCI/0. 1 M EDTA, pH 7.5) and cen-
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trifuged at 125,000 X gfor 16 hr. The RNA pellet was suspended in sterile water and precipitated and washed in ethanol. Poly(A)+RNA was isolated by passing the guanidine hydrochloride extracts through an oligo(dT)-cellulose column (15) . The RNA was reprecipitated, washed, dried under nitrogen, resuspended in sterile water (minimum volume), and stored at -700C.
Tyrosine aminotransferase mRNA activity was quantitated by translation in the rabbit reticulocyte lysate system (16) followed by immunoprecipitation of in vitro-synthesized radioactive tyrosine aminotransferase. Immunoprecipitation was by the two-step indirect method described by Ivarie and Jones (17) except that protein A-Sepharose was used in place of Staphylococcus aureus cells. Immunoprecipitates were analyzed by electrophoresis in 10% NaDodSOJpolyacrylamide gels. Frozen gels were sliced and radioactivity was extracted and assayed in 3% Protosol in Econofluor (New England Nuclear). The amount of [3S]methionine incorporated into tyrosine aminotransferase was quantitated by summing the radioactivity of the gel slices containing the peak ofthe in vitro-synthesized enzyme subunit and subtracting a background estimated from the radioactivity in the slices on either side of the peak. RNA concentrations were chosen so that the cpm incorporated into the enzyme subunit was proportional to the amount oftyrosine aminotransferase mRNA added to the translation system. The use of this assay to quantitate basal and hormone-induced levels of tyrosine aminotransferase mRNA in adult rat liver has been well established (18) .
RESULTS
Two inducers of adult liver tyrosine aminotransferase were tested for their ability to precociously induce enzyme activity in fetal rat liver. After correcting for the presence of aspartate aminotransferase (12) , virtually no tyrosine aminotransferase activity was detected in the livers of day 20 fetal rats ( Table 1) . As previously reported (6), in utero injection ofdibutyryl cAMP resulted in the appearance of catalytic activity within 6 hr. Hydrocortisone acetate injection failed to elicit the same response 6 hr after treatment (4, 6) .
In the same experiment, the level offunctional tyrosine aminotransferase mRNA was assayed to determine its relationship to catalytic activity. Poly(A)+RNA was prepared from fetal and adult liver samples and translated in the rabbit reticulocyte lysate translation system. Newly synthesized tyrosine aminotransferase was immunoprecipitated and analyzed by Na- DodSO4polyacrylamide gel electrophroesis (Fig. 1) . Translatable tyrosine aminotransferase mRNA was not detectable in salineor hydrocortisone-treated fetal rat livers (Fig. 1B) . However, mRNA activity was present in the livers of animals treated with dibutyryl cAMP, as shown by the presence of radioactive tyrosine aminotransferase (Fig. 1A) . Table 1 summarizes the tyrosine aminotransferase catalytic and mRNA activities found for the various liver samples. For comparison, basal adult values are included. The sensitivity of the translational assay is such that it is impossible to state unequivocally that tyrosine aminotransferase mRNA activity is completely absent in fetal rat liver. However, it is clear that dibutyryl cAMP markedly increased the level oftranslatable mRNA coding for tyrosine aminotransferase. The failure, of hydrocortisone acetate to precociously induce fetal liver enzyme activity in utero can be attributed to its inability to elicit the appearance of translatable mRNA coding for tyrosine aminotransferase. Neither dibutyryl cAMP nor hydrocortisone acetate significantly altered the total mRNA template activity in fetal liver.
Fetal liver explants were used to examine in more detail the hormonal factors regulating the development of tyrosine ami- notransferase activity. Uniform cubes of day 20 fetal rat liver were cultured in a chemically defined medium in the absence of serum and hormones. The morphological and functional integrity ofthese explants has been established (10) . The response offetal liver explants to hydrocortisone and dibutyryl cAMP was tested several times during 60 hr of culture. The extent of tyrosine aminotransferase induction observed at these times is shown in Fig. 2 . Addition of dibutyryl cAMP to fresh explants (0 hr in culture) produced small. but reproducible increases in activity within 12 hr. Explants cultured for 24 or 48 hr prior to dibutyryl cAMP treatment-were more responsive to the inducer. Tyrosine aminotransferase activity in these explants approached basal adult levels. Significant catalytic activity did not develop spontaneously in untreated control explants through 60 hr in culture. In contrast to its lack of effect in utero, hydrocortisone acetate was capable of inducing tyrosine aminotransferase activity in cultured liver explants. Measurable increases in enzyme activity were observed after hydrocortisone treatment of fresh explants. Again, explants cultured for 24 or 48 hr before treatment were more responsive. The time course of induction of tyrosine aminotransferase activity in 24-hr explants is shown in Fig. 3 . Enzyme activity was evident <2 hr after the addition of dibutyryl cAMP and continued to increase over the next 22 hr. After a 2-hr lag, a similar increase in enzyme activity occurred after hydrocortisone acetate treatment. The action of the steroid hormone and cAMP was prevented by inhibitors of RNA and protein synthesis, indicating that the increase in enzyme activity mediated by either inducer is the result of de novo synthesis of tyrosine aminotransferase and its mRNA (data not shown). Simultaneous addition ofdibutyryl cAMP andhydrocortisone acetate resulted in a dramatic increase in the rate of appearance of enzyme activity. This led to induced levels at 12 or 24 hr after treatment that were several times greater than the sum of the individual increases mediated by either inducer alone. The synergism between steroid hormone and cAMP action has been observed in adult liver (19) . The time course of induction of mRNA and enzyme activity in fetal liver explants is shown in Fig. 4 . With either inducer, the appearance oftyrosine aminotransferase mRNA always preceded the induction of enzyme activity. In general, the changes in catalytic activity paralleled mRNA activity except for the biphasic appearance of mRNA induced by dibutyryl cAMP (Fig.  4A) . The synergistic induction ofenzyme activity resulting from the combined action ofdibutyryl cAMP and hydrocortisone acetate was also observed at the level of tyrosine aminotransferase mRNA activity (Fig. 4) . Thus, the mechanism of induction of tyrosine aminotransferase activity by glucocorticoids and cAMP in developing rat liver is identical to that in the adult (18) . DISCUSSION Several important features ofthe control oftyrosine aminotransferase gene expression have emerged from our studies. No detectable pool oftranslatable mRNA in day 20 fetal rats was found that could account for the dramatic increase in enzyme activity seen in the newborn (Table 1) . However, we cannot exclude the possibility that a rapid accumulation of tyrosine aminotransferase mRNA occurs during the remaining 2 days of gestation.
The precocious induction of enzyme activity achieved by in utero injection of dibutyryl cAMP was found to be a direct consequence of the de novo appearance of translatable mRNA coding for tyrosine aminotransferase ( (21) . Rather, it seems that the explants are adapting to the in vitro culture conditions. The observation that hydrocortisone induces tyrosine aminotransferase catalytic and mRNA activity in vitro but not in utero suggests that culturing relieves the restrictions imposed by the uterine environment with respect to glucocorticoid action. Contrary to other reports, in vitro culture conditions alone. were insufficient to stimulate enzyme activity in the absence of added inducers (22) (23) (24) .
Either dibutyryl cAMP or hydrocortisone acetate was capable ofinducing enzyme and mRNA activity in fetal liver explants to adult levels within 12 hr. However, activity comparable with that seen in vivo in the 24 hr after birth (2 or 3 times the adult level) required the concerted action of both inducers (Fig. 4) . The presence of the steroid hormone and the cyclic nucleotide may be necessary for the dramatic increase in enzyme activity seen immediately after birth. Greengard (6) suggested that glucagon secreted in response to postnatal hypoglycemia initiates enzyme accumulation in neonatal liver. Experiments showing that premature delivery (5) or in utero injection of glucagon (4, 5) precociously induced tyrosine aminotransferase favor this hypothesis. In addition, glucose injection 2 hr after birth, when hypoglycemia is maximal, partially prevented the appearance of enzyme activity (5) . In support of a role for glucocorticoids, Sereni et al. (2) found that amphenone B, an inhibitor of corticosteroid synthesis, delayed the appearance of tyrosine aminotransferase when injected immediately after birth. Neonatal adrenalectomy also prevented the induction ofenzyme activity. This effect was reversed by injection ofglucocorticoids. Perhaps it is the synergistic interaction between glucocorticoids and glucagon (or cAMP), clearly observed in fetal liver explants, that leads to the dramatic appearance of tyrosine aminotransferase in neonatal rat liver.
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